ARCHIVES

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

This article is from The Cancer Letter archive.

Vol. 39 No. 44 | November 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites

January 3, 2014

NCAB: An Extraordinary Opportunity For Budgetary Coordination.

February 25, 2000